Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PROLACTINOMAS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 94 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stefaneanu, L; Kovacs, K; Horvath, E; Buchfelder, M; Fahlbusch, R; Lancranjan, I
      Dopamine D2 receptor gene expression in human adenohypophysial adenomas

      ENDOCRINE
    2. Castro, MG; Southgate, T; Lowenstein, PR
      Molecular therapy in a model neuroendocrine disease: developing clinical gene therapy for pituitary tumours

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    3. Fujikawa, M; Okamura, K; Sato, K; Shiratsuchi, M; Yao, T; Mizokami, T; Fujishima, M
      Multiple intracranial recurrent tumors with hyperprolactinemia combined with a parasellar malignant fibrous histiocytoma long after transfrontal surgery and irradiation to a pituitary adenoma

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    4. Cappabianca, P; Lodrini, S; Felisati, G; Peca, C; Cozzi, R; Di Sarno, A; Cavallo, LM; Giombini, S; Colao, A
      Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    5. De Menis, E; Visentin, A; Billeci, D; Tramontin, P; Agostini, S; Marton, E; Conte, N
      Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    6. Davis, JRE; McNeilly, AS
      Is pituitary gene therapy realistic?

      CLINICAL ENDOCRINOLOGY
    7. Sarkar, DK; Liehr, JG; Singletary, KW
      Role of estrogen in alcohol promotion of breast cancer and prolactinomas

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    8. Hentges, S; Sarkar, DK
      Transforming growth factor-beta regulation of estradiol-induced prolactinomas

      FRONTIERS IN NEUROENDOCRINOLOGY
    9. Nishioka, H; Ito, H; Haraoka, J; Hirano, A
      Growth potential of female prolactinomas

      SURGICAL NEUROLOGY
    10. Lohrer, P; Gloddek, J; Hopfner, U; Losa, M; Uhl, E; Pagotto, U; Stalla, GK; Renner, U
      Vascular endothelial growth factor production and regulation in rodent andhuman pituitary tumor cells in vitro

      NEUROENDOCRINOLOGY
    11. Di Sarno, A; Landi, ML; Cappabianca, P; Di Salle, F; Rossi, FW; Pivonello, R; Di Somma, C; Faggiano, A; Lombardi, G; Colao, A
      Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: Prevalence, clinical definition, and therapeutic strategy

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    12. Pombo, JLH
      Clinical management of hyperprolactinemia

      REVISTA CLINICA ESPANOLA
    13. Pena, KS; Rosenfeld, JA
      Evaluation and treatment of galactorrhea

      AMERICAN FAMILY PHYSICIAN
    14. Heaney, AP; Melmed, S
      New pituitary oncogenes

      ENDOCRINE-RELATED CANCER
    15. Honegger, J; Petrick, M
      Amenorrhea-galactorrhea syndrome in tumours of the sella region

      NERVENHEILKUNDE
    16. Berwaerts, J; Verhelst, J; Abs, R; Appel, B; Mahler, C
      A giant prolactinoma presenting with unilateral exophthalmos: Effect of cabergoline and review of the literature

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    17. Rees, DA; Davies, JS; Scanlon, MF
      Microprolactinoma: Medical or surgical treatment as first line approach? The case for medical therapy

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    18. Sasaki, R; Murakami, M; Okamoto, Y; Kono, K; Yoden, E; Nakajima, T; Nabeshima, S; Kuroda, Y
      The efficacy of conventional radiation therapy in the management of pituitary adenoma

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    19. Fideleff, HL; Boquete, HR; Sequera, A; Suarez, M; Sobrado, P; Giaccio, A
      Peripubertal prolactinomas: Clinical presentation and long-term outcome with different therapeutic approaches

      JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
    20. Colao, A; Di Sarno, A; Marzullo, P; Di Somma, C; Cerbone, G; Landi, ML; Faggiano, A; Merola, B; Lombardi, G
      New medical approaches in pituitary adenomas

      HORMONE RESEARCH
    21. Castro, MG; Cowen, R; Smith-Arica, J; Williams, J; Ali, S; Windeatt, S; Gonzalez-Nicolini, V; Maleniak, T; Lowenstein, PR
      Gene therapy strategies for intracranial tumours: glioma and pituitary adenomas

      HISTOLOGY AND HISTOPATHOLOGY
    22. Pinzone, JJ; Katznelson, L; Danila, DC; Pauler, DK; Miller, CS; Klibanski, A
      Primary medical therapy of micro- and macroprolactinomas in men

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    23. Colao, A; Di Sarno, A; Landi, ML; Scavuzzo, F; Cappabianca, P; Pivonello, R; Volpe, R; Di Salle, F; Cirillo, S; Annunziato, L; Lombardi, G
      Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: A prospective study in 110 patients

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    24. Agricola, JMC; Cabezas-Cerrato, J
      Therapeutic management of hyperprolactinemia

      REVISTA CLINICA ESPANOLA
    25. Hewage, UCL; Colman, PG; Kaye, A
      Cerebrospinal fluid (CSF) rhinorrhoea occurring six days after commencement of bromocriptine for invasive macroprolactinoma

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    26. Rohmer, V; Freneau, E; Morange, I; Simonetta, C
      Efficacy of quinagolide in resistance to ergot dopamine agonists: results of a multicenter study

      ANNALES D ENDOCRINOLOGIE
    27. Biller, BMK
      Hyperprolactinemia

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    28. Heaney, AP; Melmed, S
      Pituitary tumour transforming gene: a novel factor in pituitary tumour formation

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    29. Arica, B; Kas, HS; Sargon, MF; Acikgoz, B; Hincal, AA
      Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique II. Suitability for brain and hypophysis delivery

      STP PHARMA SCIENCES
    30. Cappabianca, P; Alfieri, A; Colao, A; Ferone, D; Lombardi, G; de Divitiis, E
      Endoscopic endonasal transsphenoidal approach: An additional reason in support of surgery in the management of pituitary lesions

      SKULL BASE SURGERY
    31. Molitch, ME
      Medical treatment of prolactinomas

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    32. Cannavo, S; Bartolone, L; Blandino, A; Spinella, S; Galatioto, S; Trimarchi, F
      Shrinkage of a PRL-secreting pituitary macroadenoma resistant to cabergoline

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    33. de Herder, WW; Reijs, AEM; de Swart, J; Kaandorp, Y; Lamberts, SWJ; Krenning, EP; Kwekkeboom, DJ
      Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D-2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    34. Yildiz, F; Zorlu, F; Erbas, T; Atahan, L
      Radiotherapy in the management of giant pituitary adenomas

      RADIOTHERAPY AND ONCOLOGY
    35. Fierz, AB; Kaufman, DI; Lee, AG; Eggenberger, ER; Friend, KE
      Cabergoline in prolactinomas

      NEURO-OPHTHALMOLOGY
    36. Guieu, R; Dufour, H; Grisoli, F; Jaquet, P; Guieu, Y; Rosso, JP; Munier, M; Dicostanzo, V; Brue, T; Enjalbert, A; Begoud, D; Rochat, H
      An ultrarapid prognostic index in microprolactinoma surgery

      JOURNAL OF NEUROSURGERY
    37. Verhelst, J; Abs, R; Maiter, D; Van den Bruel, A; Vandeweghe, M; Velkeniers, B; Mockel, J; Lamberigts, G; Petrossians, P; Coremans, P; Mahler, C; Stevenaert, A; Verlooy, J; Raftopoulos, C; Beckers, A
      Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    38. VELKENIERS B; HOOGHEPETERS EL
      FROM PROLACTIN CELL TO PROLACTINOMA - IMPLICATIONS OF ONTOGENIC MECHANISMS IN DIAGNOSIS AND MANAGEMENT

      Endocrine-related cancer
    39. COLAO A; ANNUNZIATO L; LOMBARDI G
      TREATMENT OF PROLACTINOMAS

      Annals of medicine
    40. DELGRANGE E; CRABBE J; DONCKIER J
      LATE DEVELOPMENT OF RESISTANCE TO BROMOCRIPTINE IN A PATIENT WITH MACROPROLACTINOMA

      Hormone research
    41. KWIECIEN R; HAMMOND C
      DIFFERENTIAL MANAGEMENT OF CA2-PITUITARY-CELLS - A COMPARATIVE OVERVIEW( OSCILLATIONS BY ANTERIOR)

      Neuroendocrinology
    42. Thomopoulos, P
      Medical treatment of pituitary adenomas.

      NEUROCHIRURGIE
    43. RENNER U; ARZBERGER T; PAGOTTO U; LEIMGRUBER S; UHL E; MULLER A; LANGE M; WEINDL A; STALLA GK
      HETEROGENOUS DOPAMINE D2 RECEPTOR SUBTYPE MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN CLINICALLY NONFUNCTIONING PITUITARY-ADENOMAS

      The Journal of clinical endocrinology and metabolism
    44. Kaltsas, GA; Mukherjee, JJ; Plowman, PN; Monson, JP; Grossman, AB; Besser, GM
      The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    45. SARNACCHIARO F; COLAO A; MEROLA B; DISARNO A; LANDI ML; DISOMMA C; FERONE D; TOLINO A; LOMBARDI G
      DIFFERENT SENSITIVITY TO SODIUM VALPROATE IN HEALTHY, NONTUMORAL AND TUMORAL HYPERPROLACTINEMIC SUBJECTS

      Journal of endocrinological investigation
    46. MCCORD MW; BUATTI JM; FENNELL EM; MENDENHALL WM; MARCUS RB; RHOTON AL; GRANT MB; FRIEDMAN WA
      RADIOTHERAPY FOR PITUITARY-ADENOMA - LONG-TERM OUTCOME AND SEQUELAE

      International journal of radiation oncology, biology, physics
    47. CESARIO F; BORRETTA G; MEINERI I; MURATORI M; PIZZOCARO A; BECKPECCOZ P
      COMBINED CABERGOLINE AND RECOMBINANT HUMAN GROWTH-HORMONE TREATMENT OF AN ADOLESCENT WITH A MACROPROLACTINOMA CAUSING GH DEFICIENCY

      Journal of pediatric endocrinology & metabolism
    48. LECOMTE P; LECOMTE C; LANSAC J; GALLIER J; SONIER CB; SIMONETTA C
      PREGNANCY AFTER INTRAVENOUS PULSATILE GONADOTROPIN-RELEASING-HORMONE IN A HYPERPROLACTINEMIC WOMAN RESISTANT TO TREATMENT WITH DOPAMINE AGONISTS

      European journal of obstetrics, gynecology, and reproductive biology
    49. HARAN RP; CHANDY MJ
      SYMPTOMATIC PNEUMOCEPHALUS AFTER TRANSSPHENOIDAL SURGERY

      Surgical neurology
    50. COLAO A; FERONE D; MARZULLO P; DISARNO A; CERBONE G; SARNACCHIARO F; CIRILLO S; MEROLA B; LOMBARDI G
      EFFECT OF DIFFERENT DOPAMINERGIC AGENTS IN THE TREATMENT OF ACROMEGALY

      The Journal of clinical endocrinology and metabolism
    51. CASTRO MG; GOYA RG; SOSA YE; ROWE J; LARREGINA A; MORELLI A; LOWENSTEIN PR
      EXPRESSION OF TRANSGENES IN NORMAL AND NEOPLASTIC ANTERIOR-PITUITARY-CELLS USING RECOMBINANT ADENOVIRUSES - LONG-TERM EXPRESSION, CELL-CYCLE DEPENDENCY, AND EFFECTS OIL HORMONE-SECRETION

      Endocrinology
    52. WALSH JP; PULLAN PT
      HYPERPROLACTINEMIA IN MALES - A HETEROGENEOUS DISORDER

      Australian and New Zealand Journal of Medicine
    53. JAQUET P
      QUINAGOLIDE AND MACROPROLACTINOMAS PROGRE SS

      Annales d'Endocrinologie
    54. TERADA T; STEFANEANU L; KOVACS K; SCHEITHAUER BW
      VANISHING PSAMMOMA BODIES IN THE ANTERIOR-PITUITARY OF THE HUMAN NEWBORN - AN IMMUNOHISTOCHEMICAL AND HISTOMETRIC STUDY

      Endocrine pathology
    55. CACCAVELLI L; MORANGERAMOS I; KORDON C; JAQUET P; ENJALBERT A
      ALTERATION OF G-ALPHA SUBUNITS MESSENGER-RNA LEVELS IN BROMOCRIPTINE RESISTANT PROLACTINOMAS

      Journal of neuroendocrinology
    56. SHANIS BS; CHECK JH
      RELATIVE RESISTANCE OF A MACROPROLACTINOMA TO BROMOCRIPTINE THERAPY DURING PREGNANCY

      Gynecological endocrinology
    57. MARASCHINI C; MORO M; TOJA P; BRAGA M; CAVAGNINI F
      NO DIFFERENCE BETWEEN MICRO AND MACROPROLACTINOMAS IN THE PROLACTIN RESPONSIVENESS TO METOCLOPRAMIDE AND DOPAMINE ADMINISTRATION

      Gynecological endocrinology
    58. LIUZZI A; OPPIZZI G
      MICROPROLACTINOMAS - WHY REQUIEM FOR SURGERY

      Journal of endocrinological investigation
    59. JOCKENHOVEL F; MULLERWIELAND D
      PHARMACEUTICAL TREATMENT OF PITUITARY-TUM ORS

      Onkologie
    60. MINNITI G; JAFFRAINREA ML; LUNARDI P; GULINO A; TAMBURRANO G
      15-YEAR-OLD BOY WITH OCULAR PALSY AND HEADACHE

      European journal of pediatrics
    61. DEHERDER WW; REIJS AEM; KWEKKEBOOM DJ; HOFLAND LJ; NOBELS FRE; OEI HY; KRENNING EP; LAMBERTS SWJ
      IN-VIVO IMAGING OF PITUITARY-TUMORS USING A RADIOLABELED DOPAMINE D2 RECEPTOR RADIOLIGAND

      Clinical endocrinology
    62. PIRKER W; RIEDL M; LUGER A; CZECH T; ROSSLER K; ASENBAUM S; ANGELBERGER P; KORNHUBER J; DEECKE L; PODREKA I; BRUCKE T
      DOPAMINE D2 RECEPTOR IMAGING IN PITUITARY-ADENOMAS USING IODINE-123-EPIDEPRIDE AND SPECT

      The Journal of nuclear medicine
    63. OBRIEN T; ORIORDAN DS; GHARIB H; SCHEITHAUER BW; EBERSOLD MJ; VANHEERDEN JA
      RESULTS OF TREATMENT OF PITUITARY DISEASE IN MULTIPLE ENDOCRINE NEOPLASIA, TYPE-I

      Neurosurgery
    64. OTTEN P; RILLIET B; REVERDIN A; DEMIERRE B; BERNEY J
      PROLACTIN-SECRETING ADENOMAS - SURGICAL R ESULTS

      Neuro-chirurgie
    65. TERADA T; KOVACS K; STEFANEANU L; HORVATH E
      INCIDENCE, PATHOLOGY, AND RECURRENCE OF PITUITARY-ADENOMAS - STUDY OF647 UNSELECTED SURGICAL CASES

      Endocrine pathology
    66. EGUCHI K; KAWAMOTO K; UOZUMI T; ITO A; ARITA K; KURISU K
      EFFECT OF CABERGOLINE, A DOPAMINE AGONIST, ON ESTROGEN-INDUCED RAT PITUITARY-TUMORS - IN-VITRO CULTURE STUDIES

      Endocrine journal
    67. EGUCHI K; KAWAMOTO K; UOZUMI T; ITO A; ARITA K; KURISU K
      IN-VIVO EFFECT OF CABERGOLINE, A DOPAMINE AGONIST, ON ESTROGEN-INDUCED RAT PITUITARY-TUMORS

      Endocrine journal
    68. JAQUET P
      CV-205-502 - A MORE EFFECTIVE DOPAMINE AGONIST IN THE TREATMENT OF ACROMEGALY

      European journal of endocrinology
    69. BENESCH H; FELBER SR; FINKENSTEDT G; KREMSER C; STOCKHAMMER G; AICHNER FT
      MR VOLUMETRY FOR MONITORING INTRAMUSCULAR BROMOCRIPTINE TREATMENT IN MACROPROLACTINOMAS

      Journal of computer assisted tomography
    70. SCHUSSLER N; BOULARAND S; LI JY; PEILLON F; MALLET J; BIGUET NF
      MULTIPLE TYROSINE-HYDROXYLASE TRANSCRIPTS AND IMMUNOREACTIVE FORMS INTHE RAT - DIFFERENTIAL EXPRESSION IN THE ANTERIOR-PITUITARY AND ADRENAL-GLAND

      Journal of neuroscience research
    71. COLAO A; MEROLA B; SARNACCHIARO F; DISARNO A; LANDI ML; MARZULLO P; CERBONE G; FERONE D; LOMBARDI G
      COMPARISON AMONG DIFFERENT DOPAMINE-AGONISTS OF NEW FORMULATION IN THE CLINICAL MANAGEMENT OF MACROPROLACTINOMAS

      Hormone research
    72. ANSON JA; SEGAL MN; BALDWIN NG; NEAL D
      RESECTION OF GIANT INVASIVE PITUITARY-TUMORS THROUGH A TRANSFACIAL APPROACH - TECHNICAL CASE-REPORT

      Neurosurgery
    73. DEROME PJ
      RESECTION OF GIANT INVASIVE PITUITARY-TUMORS THROUGH A TRANSFACIAL APPROACH - TECHNICAL CASE-REPORT - COMMENTS

      Neurosurgery
    74. ZONSZEIN J
      DIAGNOSIS AND MANAGEMENT OF ENDOCRINE DISORDERS OF ERECTILE DYSFUNCTION

      Urologic clinics of North America
    75. WALLACE EA; HOLDAWAY IM
      TREATMENT OF MACROPROLACTINOMAS AT AUCKLAND-HOSPITAL 1975-91

      New Zealand medical journal
    76. SCILLITANI A; DICEMBRINO F; DIFAZIO P; VETTORI PP; DANGELO V; SCARABINO T; LIUZZI A
      IN-VIVO VISUALIZATION OF PITUITARY DOPAMINERGIC RECEPTORS BY I-123 METHOXYBENZAMIDE (IBZM) CORRELATES WITH SENSITIVITY TO DOPAMINE AGONISTSIN 2 PATIENTS WITH MACROPROLACTINOMAS

      The Journal of clinical endocrinology and metabolism
    77. JONES TH
      THE MANAGEMENT OF HYPERPROLACTINEMIA

      British Journal of Hospital Medicine
    78. MEROLA B; SARNACCHIARO F; COLAO A; DISOMMA C; DISARNO A; FERONE D; SELLERI A; LANDI ML; SCHETTINI G; NAPPI C; LOMBARDI G
      POSITIVE RESPONSE TO COMPOUND CV-205-502 IN HYPERPROLACTINEMIC PATIENTS RESISTANT TO OR INTOLERANT OF BROMOCRIPTINE

      Gynecological endocrinology
    79. MEROLA B; SARNACCHIARO F; COLAO A; DISOMMA C; DISARNO A; LANDI ML; MARZULLO P; PANZA N; BATTISTA C; LOMBARDI G
      CV-205-502 IN THE TREATMENT OF TUMORAL AND NONTUMORAL HYPERPROLACTINEMIC STATES

      Biomedicine & pharmacotherapy
    80. PIRKER W; BRUCKE T; RIEDL M; CLODI M; LUGER A; ASENBAUM S; PODREKA I; DEECKE L
      IODINE-123-IBZM-SPECT - STUDIES IN 15 PATIENTS WITH PITUITARY-TUMORS

      Journal of neural transmission
    81. VILAR L; BURKE CW
      QUINAGOLIDE EFFICACY AND TOLERABILITY IN HYPERPROLACTINEMIC PATIENTS WHO ARE RESISTANT TO OR INTOLERANT OF BROMOCRIPTINE

      Clinical endocrinology
    82. COOK RJ; UTTLEY D; WILKINS PR; ARCHER DJ; BELL BA
      PROLACTINOMAS IN MEN MASQUERADING AS INVASIVE SKULL BASE TUMORS

      British journal of neurosurgery
    83. TAKECHI A; UOZUMI T; KAWAMOTO K; ITO A; KURISU K; SUDO K
      INHIBITORY EFFECT OF TNP-470, A NEW ANTI-ANGIOGENIC AGENT, ON THE ESTROGEN-INDUCED RAT PITUITARY-TUMORS

      Anticancer research
    84. BARLAS O; BAYINDIR C; HEPGUL K; CAN M; KIRIS T; SENCER E; UNAL F; ARAL F
      BROMOCRIPTINE-INDUCED CEREBROSPINAL-FLUID FISTULA IN PATIENTS WITH MACROPROLACTINOMAS - REPORT OF 3 CASES AND A REVIEW OF THE LITERATURE

      Surgical neurology
    85. ESPINOS JJ; RODRIGUEZESPINOSA J; WEBB SM; CALAFALSINA J
      LONG-ACTING REPEATABLE BROMOCRIPTINE IN THE TREATMENT OF PATIENTS WITH MICROPROLACTINOMA INTOLERANT OR RESISTANT TO ORAL DOPAMINERGICS

      Fertility and sterility
    86. SCHWARZSTEIN D; GARCIAPATTERSON A; GIMENEZ G; CALAF J; PUIGDOMINGO M; CAIXAS A; MATIASGUIU X; WEBB SM
      DOPAMINERGIC RESISTANCE IN A CASE OF INVASIVE MACROPROLACTINOMA

      Journal of endocrinological investigation
    87. HUGHES MN; LLAMAS KJ; YELLAND ME; TRIPCONY LB
      PITUITARY-ADENOMAS - LONG-TERM RESULTS FOR RADIOTHERAPY ALONE AND POSTOPERATIVE RADIOTHERAPY

      International journal of radiation oncology, biology, physics
    88. VERHOEFF NPLG; BEMELMAN FJ; WIERSINGA WM; VANROYEN EA
      IMAGING OF DOPAMINE D2 AND SOMATOSTATIN RECEPTORS INVIVO USING SINGLE-PHOTON EMISSION TOMOGRAPHY IN A PATIENT WITH A TSH PRL-PRODUCING PITUITARY MACROADENOMA

      European journal of nuclear medicine
    89. RAZZAQ R; OHALLORAN DJ; BEARDWELL CG; SHALET SM
      THE EFFECTS OF CV205-502 IN PATIENTS WITH HYPERPROLACTINEMIA INTOLERANT AND OR RESISTANT TO BROMOCRIPTINE

      Hormone research
    90. BRISMAN MH; FETELL MR; POST KD
      REVERSIBLE DEMENTIA DUE TO MACROPROLACTINOMA - CASE-REPORT

      Journal of neurosurgery
    91. MOLITCH ME
      INCIDENTAL PITUITARY-ADENOMAS

      The American journal of the medical sciences
    92. TYSON D; REGGIARDO D; SKLAR C; DAVID R
      PROLACTIN-SECRETING MACROADENOMAS IN ADOLESCENTS - RESPONSE TO BROMOCRIPTINE THERAPY

      American journal of diseases of children [1960]
    93. MEROLA B; SARNACCHIARO F; COLAO A; DISOMMA C; DISARNO A; CARUSO E; LOMBARDI G
      USEFULNESS OF CV 205-502 IN A CASE OF ALLERGY TO ERGOT-DERIVED DRUGS

      Hormone research
    94. CACCAVELLI L; CUSSAC D; PELLEGRINI I; AUDINOT V; JAQUET P; ENJALBERT A
      D2 DOPAMINERGIC RECEPTORS - NORMAL AND ABNORMAL TRANSDUCTION MECHANISMS

      Hormone research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 05:03:55